NO933272D0 - Reseptor for human follikel stimulerende hormon - Google Patents

Reseptor for human follikel stimulerende hormon

Info

Publication number
NO933272D0
NO933272D0 NO933272A NO933272A NO933272D0 NO 933272 D0 NO933272 D0 NO 933272D0 NO 933272 A NO933272 A NO 933272A NO 933272 A NO933272 A NO 933272A NO 933272 D0 NO933272 D0 NO 933272D0
Authority
NO
Norway
Prior art keywords
receptor
mutant
fragment
human
fsh
Prior art date
Application number
NO933272A
Other languages
English (en)
Other versions
NO315517B1 (no
NO933272L (no
Inventor
Christie Ann Kelton
Shirley Vui Yen Cheng
Patrice Noreen
Rene Lynn Schweickhardt
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24688922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO933272(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO933272L publication Critical patent/NO933272L/no
Publication of NO933272D0 publication Critical patent/NO933272D0/no
Publication of NO315517B1 publication Critical patent/NO315517B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
NO19933272A 1991-03-15 1993-09-14 Polypeptid som er i stand til a gjenkjenne og selektivt binde humant FSH, DNA som koder for dette, rekombinant ekspresjonsvektor inneholdende dette DNA, celle transfektert med ekspresjonsvektoren, fremgangsmate for fremstilling av polypeptidet, farmasoyti NO315517B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67008591A 1991-03-15 1991-03-15
PCT/US1992/000122 WO1992016620A1 (en) 1991-03-15 1992-01-02 Human follicle stimulating hormone receptor

Publications (3)

Publication Number Publication Date
NO933272L NO933272L (no) 1993-09-14
NO933272D0 true NO933272D0 (no) 1993-09-14
NO315517B1 NO315517B1 (no) 2003-09-15

Family

ID=24688922

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19933272A NO315517B1 (no) 1991-03-15 1993-09-14 Polypeptid som er i stand til a gjenkjenne og selektivt binde humant FSH, DNA som koder for dette, rekombinant ekspresjonsvektor inneholdende dette DNA, celle transfektert med ekspresjonsvektoren, fremgangsmate for fremstilling av polypeptidet, farmasoyti

Country Status (19)

Country Link
US (3) US5744448A (no)
EP (2) EP1167385B1 (no)
JP (1) JP3581148B2 (no)
KR (1) KR100245250B1 (no)
AT (2) ATE224446T1 (no)
AU (1) AU671417B2 (no)
CA (1) CA2106061C (no)
DE (2) DE69233805D1 (no)
DK (1) DK0575357T3 (no)
ES (1) ES2183806T3 (no)
FI (1) FI109360B (no)
GE (1) GEP19991604B (no)
LT (1) LT3973B (no)
LV (1) LV10724B (no)
MX (1) MX9203350A (no)
NO (1) NO315517B1 (no)
RU (1) RU2193599C2 (no)
UA (1) UA43826C2 (no)
WO (1) WO1992016620A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993020199A1 (en) * 1992-03-30 1993-10-14 Akzo Nobel N.V. Human gonadotropin receptor (fsh receptor)
SI0894141T1 (en) 1996-02-20 2005-10-31 Applied Research Systems Ars Holding N.V. Hybrid proteins which form heterodimers
CA2250975A1 (en) * 1996-04-15 1997-10-23 The Board Of Trustees Of The Leland Stanford Junior University Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
US6521641B1 (en) 1998-10-08 2003-02-18 Allergan, Inc. Male anti-fertility agents
WO2000073416A1 (en) * 1999-05-28 2000-12-07 University Of Cincinnati Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
EP1287135A2 (en) * 2000-05-18 2003-03-05 Bayer Aktiengesellschaft Regulation of human follicle stimulating hormone-like g protein-coupled receptor
US20030175889A1 (en) * 2002-01-23 2003-09-18 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated versions of human G protein coupled receptor: FSHR
EP1466620A1 (en) * 2003-04-11 2004-10-13 AXXAM S.r.l. Compounds modulating FSHR and therapeutic uses thereof
US20100061976A1 (en) * 2008-07-24 2010-03-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652450A (en) * 1984-08-31 1987-03-24 Research Corporation Bacterial FSH binding inhibitor
US4761371A (en) 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US4921808A (en) * 1986-06-25 1990-05-01 The Albany Medical College Of Union University Method for determining follicle stimulating hormone
US4960700A (en) * 1986-12-24 1990-10-02 Genentech, Inc. Compositions and methods for the synthesis and assay of a mammalian enkephalinase
JPH04505103A (ja) * 1989-05-05 1992-09-10 ジェネンテク，インコーポレイテッド 糖タンパク質ホルモン受容体分子
US5155218A (en) * 1990-05-08 1992-10-13 Neurogenetic Corporation Dna encoding human 5-ht1d receptors

Also Published As

Publication number Publication date
AU1251492A (en) 1992-10-21
DE69232779D1 (de) 2002-10-24
FI109360B (fi) 2002-07-15
ATE224446T1 (de) 2002-10-15
FI934023A (fi) 1993-09-14
UA43826C2 (uk) 2002-01-15
MX9203350A (es) 1992-08-01
ES2183806T3 (es) 2003-04-01
US5744448A (en) 1998-04-28
JPH06505157A (ja) 1994-06-16
DE69233805D1 (de) 2011-05-26
DE69232779T2 (de) 2003-01-30
LT3973B (en) 1996-05-27
WO1992016620A1 (en) 1992-10-01
CA2106061A1 (en) 1992-09-16
AU671417B2 (en) 1996-08-29
LTIP1631A (en) 1995-07-25
EP0575357A1 (en) 1993-12-29
LV10724B (en) 1995-12-20
JP3581148B2 (ja) 2004-10-27
NO315517B1 (no) 2003-09-15
EP1167385A3 (en) 2003-04-16
RU2193599C2 (ru) 2002-11-27
KR100245250B1 (en) 2000-02-15
FI934023A0 (fi) 1993-09-14
NO933272L (no) 1993-09-14
ATE505486T1 (de) 2011-04-15
LV10724A (lv) 1995-06-20
US6372711B1 (en) 2002-04-16
EP1167385B1 (en) 2011-04-13
GEP19991604B (en) 1999-04-29
CA2106061C (en) 2008-10-07
DK0575357T3 (da) 2002-11-25
EP0575357B1 (en) 2002-09-18
US6121016A (en) 2000-09-19
EP1167385A2 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
MY102029A (en) Human factor viii, compositions containing it, methods and materials for use in its production
DK0440777T3 (da) Neurotrofisk faktor stammende fra hjernen
DE69330521D1 (de) Radioaktiv-markierte peptidderivate des somatostatin zur bildformenden und therapeutischen verwendung
GR3030141T3 (en) Diphtheria toxin receptor-binding region.
SE8603966L (sv) Fluoroaluminosilikatglaspulver for dentalglasjonomercement
EP0861261A4 (en) NUCLEOTID AND PROTEIN SEQUENCES OF DELTA GENES FROM VERTEBRATEN AND METHODS BASED ON THEM
DE69631544D1 (de) Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse
NO933272L (no) Reseptor for human follikel stimulerende hormon
ZA918876B (en) Avirulent microbes and uses therefor:salmonella typhi
DK0588118T3 (da) Carboxypeptidaselignende protein knyttet til knogler samt fremgangsmåde til fremstilling deraf
ATE221123T1 (de) Glykoprotein-hormonrezeptor-moleküle
IL73721A (en) (4-and/or 6-substituted o-acyl)glycosylamides,ureas and carbamates,their preparation and pharmaceutical compositions containing them
RU93057956A (ru) Рецептор, днк, вектор, клетка, способ получения рецептора, фармацевтическая композиция, способы анализа, способ снижения биоактивности, способы предупреждения спермадогенеза и созревания фолликулов
GR3018837T3 (en) Subcutaneous administration of human chorionic gonadotrophin.
MX9709294A (es) Factor de crecimiento de tejido conectivo.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO, NO

MK1K Patent expired